Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Select Medical Holdings (SEM) Asset Writedowns and Impairment: 2009-2024

Historic Asset Writedowns and Impairment for Select Medical Holdings (SEM) over the last 16 years, with FY2024 value amounting to $19.0 million.

  • Select Medical Holdings' Asset Writedowns and Impairment fell 9466.19% to $506000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 6316.46%. This contributed to the annual value of $19.0 million for FY2024, which is 174834.95% up from last year.
  • Per Select Medical Holdings' latest filing, its Asset Writedowns and Impairment stood at $19.0 million for FY2024, which was up 174834.95% from $1.0 million recorded in FY2023.
  • In the past 5 years, Select Medical Holdings' Asset Writedowns and Impairment registered a high of $19.0 million during FY2024, and its lowest value of $174000.0 during FY2022.
  • Its 5-year average for Asset Writedowns and Impairment is $4.2 million, with a median of $604000.0 in 2020.
  • As far as peak fluctuations go, Select Medical Holdings' Asset Writedowns and Impairment plummeted by 9727.07% in 2020, and later soared by 174834.95% in 2024.
  • Select Medical Holdings' Asset Writedowns and Impairment (Annual) stood at $604000.0 in 2020, then plummeted by 60.93% to $236000.0 in 2021, then fell by 26.27% to $174000.0 in 2022, then skyrocketed by 491.95% to $1.0 million in 2023, then surged by 1748.35% to $19.0 million in 2024.
  • Its Asset Writedowns and Impairment was $19.0 million in FY2024, compared to $1.0 million in FY2023 and $174000.0 in FY2022.